30. LYMPHEDEMA

Published on 09/04/2015 by admin

Filed under Hematology, Oncology and Palliative Medicine

Last modified 09/04/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1608 times

CHAPTER 30. LYMPHEDEMA
Jane M. Armer and Sheila H. Ridner

DEFINITION AND INCIDENCE

Lymphedema is a condition in which excessive fluid and protein accumulate in the extravascular and interstitial space. This occurs when the lymphatic system cannot either accept or transport lymph (the colorless fluid that bathes the cells of the body, carrying away byproducts of metabolism and helping to fight infection) into the circulatory system (Browse, Burnand, & Mortimer, 2003; Rockson, 2001). Primary lymphedema due to genetic and familial abnormalities in the lymphatic structure or function may occur in 1 of every 10,000 individuals (Townsend, Beauchamp, Evers et al., 2001). Incidence of secondary lymphedema varies depending on the cause. For example, 15% to 20% of breast cancer survivors in the United States may develop lymphedema, and approximately 90 million individuals worldwide may have secondary lymphedema caused by filarial (parasitic) infections (Petrek, Pressman, & Smith, 2000; Townsend et al., 2001). Although the occurrence of lymphedema in palliative care settings is unknown, one lymphedema clinic reported that approximately 30% of their clients were advanced cancer patients with lower limb swelling (Logan, 1995), and lymphedema is cited in the literature as a distressful symptom experienced by patients in palliative care settings (Winn & Dentino, 2004).
Lymphedema is a chronic medical condition requiring careful management. Because lymphedema can develop at any time throughout life (Browse et al., 2003; Foldi, Foldi, & Kubik, 2003), the clinician may have to address both recent-onset (acute) and long-existing (chronic) lymphedema in patients receiving palliative care.

ETIOLOGY AND PATHOPHYSIOLOGY

In healthy individuals, blood capillaries and lymphatic structures support fluid exchange at the blood capillary–interstitial–lymphatic interface. Capillary pressure, negative interstitial pressure, and interstitial fluid colloid osmotic pressure collectively exert approximately 41 mm Hg outward pressure, and plasma colloid osmotic pressure exerts 28 mm Hg inward pressure, resulting in a net filtration pressure of 13 mm Hg from the arterial side of capillaries into the interstitial space (Guyton & Hall, 2000). Approximately 90% of this fluid reenters the blood circulatory system through venous ends of capillaries, and the remaining 10% enters lymphatic collectors. Fluid return to the venous end of the capillary is facilitated by the net venous reabsorption pressure of 7 mm Hg created by the imbalance between capillary, negative interstitial, and interstitial fluid colloid pressure of 21 mm Hg outward pressure and the inward plasma colloid osmotic pressure of 28 mm Hg (Guyton & Hall, 2000). Fluid and the larger protein molecules enter the lymphatic system through small one-way valves and are moved by contraction of lymphangions (segments of vessels), contraction of surrounding muscles, and contractile filaments in the endothelial cells through the lymphatic vessels into the blood circulatory system (Ridner, 2002).
When the lymphatic system can no longer transport the normal fluid and protein load or when there is reduced lymphatic transport capacity coupled with increased lymph, lymphedema develops (Browse et al., 2003; Foldi et al., 2003). Lymphedema can arise from either primary (idiopathic) or secondary (acquired) conditions. Primary lymphedema occurs in the presence of malformation of lymph vessels and/or lymph nodes and is associated with many medical conditions (Table 30-1). Primary lymphedema is classified based on timing of first noted swelling (Foldi et al., 2003):
TABLE 30-1 Lymphedema: Etiologies and Causes
Primary Lymphedema: Associated Diseases
Nonne-Milroy syndrome Hennekam syndrome
Turner syndrome Mixed vascular and lymphatic disorders
Noonan syndrome Milroy syndrome
Fibrosis of inguinal nodes Meige syndrome
Yellow nail syndrome Lymphedema and distichiasis
Adams-Olivier syndrome Neurofibromatosis
Proteus syndrome Aagenaes syndrome
Klippel-Trenaunay syndrome Prader-Willi syndrome
Secondary Lymphedema: Selected Causes
Category Examples
Infection Filariasis, tuberculosis, toxoplasmosis, postsurgical infection
Trauma Surgery, automobile accident, crush injuries, burns, vein removal, self-inflicted injury
Cancer and cancer treatment Tumor occluding lymphatic structures (new or recurrent), lymphatic-infiltrating metastatic disease, Kaposi’s sarcoma, surgery, radiation, and postsurgical infection
Venous disease Postthrombic conditions, venous ulcerations, intravenous drug abuse causing venous thrombosis and/or abscesses
Immobility Paralysis, extreme fatigue, venous stasis
Inflammation Rheumatoid arthritis, dermatitis, psoriasis
▪ Congenital lymphedema, present at birth
▪ Lymphedema praecox, develops after birth but before age 35
▪ Lymphedema tarda, develops after age 35
Secondary lymphedema, lymphedema with a known cause, is the most common lymphedema in developed countries (see Table 30-1). It can occur immediately after the known insult to the lymphatic system or have a latency stage and appear many years later (Foldi et al., 2003). Any patient who has had a lymph node dissection or a tumor that impedes lymphatic circulation is at risk for developing lymphedema.
Both primary and secondary lymphedema may appear first as acute and then chronic disease (lasting longer than 6 months) that can progress over time through three stages of severity. Physical presentation of swelling is the same regardless of cause. Initially, in grade I, the limb will swell and pit with pressure, and elevation will relieve the swelling. In grade II, the limb will become firmer, not pit with pressure, and skin changes, hair loss, and alteration in nails may be noted. In grade III, elephantiasis results with very thick skin and large skin folds (Pain & Purushotham, 2000).

ASSESSMENT AND MEASUREMENT

Lymphedema assessment may entail evaluation of new-onset acute swelling or preexisting lymphedema. In both cases, it is imperative to assess immediately for infection and, if present, initiate treatment (Feldman, 2005; Olszewski, 2005; Weissleder & Schuchhardt, 2001) (Table 30-2). Awakening with a hot, painful, swollen limb may be the first sign or symptom of lymphedema onset. Likewise, individuals with chronic lymphedema can rapidly develop cellulitis or lymphangitis. Infections can quickly escalate into emergency situations such as life-threatening septicemia. When assessing infection, look for redness, spreading either locally or in a distinct red line. Touch the area to determine if it is warm and/or painful. Observe for oozing or drainage in the area. Check the patient’s temperature. Palpate for enlarged nodes. Many patients report feeling flu-like symptoms both before and after immediate signs of infection, so inquire about aching, fatigue, nausea, vomiting, weakness, dizziness, chills, or sweating. Any of these signs or symptoms requires immediate antibiotic treatment, and, in the case of a patient near end-of-life, hospitalization may be considered.
TABLE 30-2 Lymphedema: Assessment Checklist
Symptom Yes No
Bruising
Rash
Blistering
Dusky in color
Unusual hair loss
Swelling
Enlarged lymph node
Oozing fluid
Pitting with pressure
Hard, nonpitting
Dry and/or flaky
Hard, nonpitting
Raised lumps
Cracking
Warm to touch
Cool to touch
When an infection is present and appropriately treated and if no signs or symptoms of infection are noted, both subjective and objective manifestations of lymphedema and associated psychological sequelae should be assessed.

Subjective Symptoms

Subjective indicators may include patient-reported swelling, jewelry or clothing feeling tight, and feeling of heaviness in limbs (Armer, Radina, Porock et al., 2003). For patients with chronic lymphedema, alteration in limb sensation (heaviness, tightness, aching, burning, swelling, hardness, stabbing, pins and needles, and numbness) and fatigue may be reported (Armer & Porock, 2001; Ridner, 2005). Patients may also report a decrease or change in physical activity and demonstrate signs of psychological distress, such as depressed mood, frustration, anger about the swelling, and feeling helpless to manage their condition (Ridner, 2005). These subtle or overt changes in sensation may be the first indicators of lymphedema, lymphedema progression, or complications such as infection prior to objective changes.

Objective Signs

Currently, there is no accepted “gold standard” for objective measurement of limb swelling associated with lymphedema. However, multiple methods can be used to measure swelling in affected limbs: (1) water displacement, (2) limb girth measured in cm with a tape measure, (3) infrared laser scanning, and (4) bioelectrical impedance. It is notable that swelling associated with truncal, breast, genital, and head and neck lymphedema may be best assessed with subjective symptom report and observation, as objective fluid assessment measurements are, at best, limited.
Water displacement: Patients are required to remove clothing covering the swollen limb and then to place the uncovered limb in a cylinder of water. The amount of water displaced by the limb estimates the limb volume (Megens, Harris, Kim-Sing et al., 2001). Limbs with wounds cannot be assessed with water displacement. End-of-life patients may be too frail, weak, and fatigued to extend the limb vertically into the water displacement volumeter until overflow dripping stops.
Circumferential measurement: Patients must remove all limb coverings and sit, extending limbs horizontally while measurement increments are marked on their skin or on a strip of adhesive tape attached to the skin. A nonstretch tape is then placed around the limb at intervals of 10, 5, or 4 cm from wrist to axilla or ankle to groin. Both limbs are measured for comparison at similar anatomic or centimeter locations, or total bilateral limb volume is calculated for comparison. This is the most commonly used method of limb volume measurement in clinical settings; however, measurement error may potentially mask lymphedema occurrence or progression or falsely implied lymphedema (Armer, 2005).
Perometer: This optoelectronic volumetry device (Juzo, Cuyahoga Falls, OH) uses infrared laser technology (Petlund, 1991). The perometer estimates total limb volume and records limb shape, using PeroPlus computer software (Juzo, 2002). Clothing must be removed from the limb before measurement. The size and nonportable nature of the machine require that patients come into the clinic for limb measurement.
Bioelectrical impedance: A bioelectrical impedance device known as the Lymphometer (ImpediMed, Queensland, Australia) is being used in research settings to estimate limb volume and assess presence of lymphedema. This device uses low-voltage electric current to determine extracellular fluid (lymph) (Cornish, Chapman, Thomas et al., 2000). Clothing remains on, the procedure is quick and painless, and the device is portable.
Varying standards are used to diagnose lymphedema. For example, a 2- to 10-cm increase in circumference, 200-ml limb volume increase, or a 5% to 10% limb volume increase, compared with prior measurements in the same area or to the contralateral limb, is a standard for the definition of lymphedema as cited in the literature (Bland, Perczyk, Du et al., 2003). Thus, measurements falling within these ranges may indicate lymphedema. When using bioelectrical impedance, ratios of affected to unaffected limb volumes are calculated; manufacturer-suggested cut points for possible lymphedema have been established.
In addition to actual volume measurement, asymmetry in limbs, head and neck, trunk, or genital areas due to swelling secondary to lymph fluid accumulation may be observed. In some cases, Stemmer’s sign may be present. This skinfold sign is typically assessed by placing a finger on each side of the base of a toe or finger and squeezing gently; in addition, use of this technique in other body segments, such as limbs and trunk, has been documented (Weissleder & Schuchhardt, 2001). When lymphedema is present, a thickening of this fold is noted when compared to a nonlymphedematous digit. However, the absence of Stemmer’s sign does not rule out lymphedema.

HISTORY AND PHYSICAL EXAMINATION

When conducting a history and physical examination of a patient with lymphedema, it is important to keep in mind possible differential (or comorbid) diagnoses, such as myxedema, lipidema, deep vein thrombosis, cancer recurrence, chronic venous insufficiency, cellulitis, or other infections (Rockson, 2001).
History should include the following:
▪ Review of all current and prior medical diagnoses including infections
▪ Course of current illness including onset (new or preexisting) of swelling, location of swelling, and exacerbation and remission of symptoms
▪ Review of current medications and medical treatment (e.g., radiation, surgery, antibiotic therapy, etc.)
▪ Review of possible causes (surgery, tumor, previous trauma)
▪ Family history of lymphedema or possibly undiagnosed chronic limb and/or body swelling
▪ Symptom review: heaviness or other sensations in affected area, skin crease depth in limb, perceived swelling, tighter-fitting clothing or jewelry on the affected side, pain, decrease or difficulty in mobility
Physical examination should include the following:
▪ Location and spread of swelling
▪ Signs of infection as previously discussed
▪ Volume measurement if possible
▪ Determination of stage of lymphedema
▪ Skin assessment (see Table 30-2)

DIAGNOSTICS

Lymphedema onset is often multifactorial and challenging to diagnose in palliative care settings (Cheville, 2002). For this reason, it is helpful to distinguish between the progression of established lymphedema due to diminished efficacy of treatment and edema related to direct tumor spread and/or other systemic factors (Cheville, 2002

Buy Membership for Hematology, Oncology and Palliative Medicine Category to continue reading. Learn more here